Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma

NCT03110640 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

B-cell Adult Acute Lymphoblastic Leukemia
B-cell Chronic Lymphocytic Leukemia
Adult Acute Lymphoblastic Leukemia in Remission
Hematopoietic/Lymphoid Cancer
Refractory Chronic Lymphocytic Leukemia

Interventions

BIOLOGICAL: anti-CD19 CAR-T
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

First Affiliated Hospital of Wenzhou Medical University

Collaborators

[object Object]
[object Object]